We all know George W. Bush doesn’t like to admit mistakes, preferring to flip-flop without acknowledging it when mistakes become unsustainable. And we also know that he has gone longer without vetoing a congressional bill than any president in living memory–rarely even rattling a veto pen as a threat.So what to make of his sudden announcement late last week that he would veto any effort to change the 2003 Medicare Rx drug bill that’s become an ongoing source of embarassment to the administration, and a potential multi-facted disaster in the future?It’s hard to find a recent domestic policy initiative that was born in such a series of Keystone Kops capers. The administration’s claims that the benefit would cost a mere $400 billion over five years–a number that only passed the laugh test because the benefit’s implementation was deliberately delayed until 2006–was widely disputed at the time. The House, famously, had to keep the roll call open for, oh, about fifteen times the normal period in order to get the votes to pass it, and succeeded, famously, only after a series of thuggish threats and blanishments, one of which earned Tom DeLay one of his three reprimands from the Ethics Committee last year.Meanwhile, as GOPers high-fived themselves for coming up with an approach to a hot-button issue that would stoke up health care industry donations while making seniors feel all warm and cuddly inside, the ink was barely dry before it became apparent old folks didn’t much like it. Even the easy part–accepting a drug discount card–wasn’t popular, even though millions of Medicare beneficiaries were signed up automatically. And as we get closer to the implementation of the full Rx drug program, with its steep premiums, skimpy coverage, and wildly complicated structure, it isn’t likely to become the biggest senior sensation since Viagra (even if Viagra is, as reported, covered by the benefit).I mention all this to provide the proper perspective for Bush’s banty rooster crowing about his brave stance in defense of his Medi-Mess.”I signed Medicare reform proudly and any attempt to limit the choices of our seniors and to take away their prescription drug coverage under Medicare will meet my veto,” quoth he, calling the Rx drug benefit “a landmark achievement in American health care.”It was a landmark, all right, but not one of achievement, but of obfuscation and deliberate efforts to mislead the country in the dogged pursuit of power.
TDS Strategy Memos
Latest Research from:
Editor’s Corner
By Ed Kilgore
-
March 6: Trump Job Approval Again Underwater, Where It Belongs
As an inveterate poll-watcher, I have been waiting for the moment when Donald Trump’s job approval numbers went underwater, his accustomed position for nearly all of his presidential career. It arrived around the time he made his speech to Congress, as I noted at New York:
Even as he was delivering the most partisan address to Congress maybe ever, Donald Trump’s public support seemed to be regularly eroding. An updated FiveThirtyEight average of Trump’s approval ratings on March 4 (released just as news broke that ABC was shutting down the revered data site) showed him going underwater for the first time since reoccupying the White House, with 47.6 percent approval and 47.9 percent disapproval. That puts Trump back in the same territory of public opinion he occupied during his first term as president, where (per Gallup) he never achieved more than 50 percent job approval, and averaged a mere 41 percent.
Perhaps Trump will get lucky and conditions in the country will improve enough to validate his agenda, but it’s more likely that the same sour public climate that overwhelmed Joe Biden will now afflict his predecessor and successor.
The Reuters/Ipsos survey that pushed Trump’s numbers into negative territory showed a mood very different from the 47th president’s boasts about a new “golden age” for our country:
“Thirty-four percent of Americans say that the country is headed in the right direction, compared to 49% who say it is off on the wrong track. When it comes to several specific issues, Americans are more likely to say things are off on the wrong track than going in the right direction: cost of living (22% right direction / 60% wrong track), the national economy (31% right direction / 51% wrong track), national politics (33% right direction / 50% wrong track), American foreign policy (33% right direction / 49% wrong track), and employment and jobs (33% right direction / 47% wrong track).”
So all the hype about Trump being a popular president who was in the midst of engineering a major realignment of the American electorate is already looking more than a bit hollow. Trump has a solid Republican base of support and a solid Democratic opposition, with independents currently leaning towards the Democratic Party on most issues. Perhaps Trump’s agenda will gain momentum and support, but since he’s not trying to reach out beyond his party’s base at all, he’s going to need a lift from Americans who only voted for him in 2024 as the lesser of evils and may not vote in the 2026 midterms at all.
At present Trump has lost whatever presidential “honeymoon” he initially enjoyed after his return to the White House, and needs to find new converts to return to genuine popularity. He’s not off to a great start.